Clinical trial
A Prospective, Multicenter, Single-group Target Value Clinical Study to Evaluate the Safety and Efficacy of JensClip Transcatheter Valve Repair System in the Treatment of Moderate to Severe Degenerative Mitral Regurgitation
NCT05417945 is registered in ClinicalTrials.gov with Jenscare Scientific as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single-group Target Value Clinical Study to Evaluate the Safety and Efficacy of JensClip Transcatheter Valve Repair System in the Treatment of Moderate to Severe Degenerative Mitral Regurgitation
- Lead sponsor
- Jenscare Scientific
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2022
- Completion date
- December 31, 2024
- Enrollment
- 124 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative mitral valve disease, mitral valve regurgitation